Bang Xi Wan
Direktor/Vorstandsmitglied bei Zhejiang Taimei Medical Technology Co., Ltd.
Profil
Bang Xi Wan is currently the Executive Director & President-Pharmacovigilance at Zhejiang Taimei Medical Technology Co., Ltd.
Prior to this role, Mr. Wan obtained an MBA from Tongji University in 2013 and an undergraduate degree from Xi'an Jiaotong University in 2004.
Aktive Positionen von Bang Xi Wan
Unternehmen | Position | Beginn |
---|---|---|
Zhejiang Taimei Medical Technology Co., Ltd.
Zhejiang Taimei Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Zhejiang Taimei Medical Technology Co., Ltd. operates as a technology solution provider in the field of life sciences with a focus on clinical research and pharmacovigilance. The firm produces products for clinical research, pharmacovigilance and other fields including MobileMD-EDC system and CTMS clinical trial management system. Its product TMCloud, a platform for pharmaceutical enterprises, research and development service companies, research institutions, patients and regulatory agencies. The company was founded by Liang Xiao and Lu Zhao on June 6, 2013 and is headquartered in Jiaxing, China. | Direktor/Vorstandsmitglied | 10.09.2020 |
Ausbildung von Bang Xi Wan
Tongji University | Masters Business Admin |
Xi'an Jiaotong University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Zhejiang Taimei Medical Technology Co., Ltd.
Zhejiang Taimei Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Zhejiang Taimei Medical Technology Co., Ltd. operates as a technology solution provider in the field of life sciences with a focus on clinical research and pharmacovigilance. The firm produces products for clinical research, pharmacovigilance and other fields including MobileMD-EDC system and CTMS clinical trial management system. Its product TMCloud, a platform for pharmaceutical enterprises, research and development service companies, research institutions, patients and regulatory agencies. The company was founded by Liang Xiao and Lu Zhao on June 6, 2013 and is headquartered in Jiaxing, China. | Technology Services |